Clinical Trials Browser

Phase 1/2 × OTHER × nimotuzumab × Clear all

NCT05278728 2025-02-07

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT01861223 2014-02-25

Afatinib Plus Nimotuzumb for NSCLC

Phase 1/2 Unknown

NSCLC

NCT01993784 2013-11-25

Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.

Phase 1/2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma